Published in Exp Ther Med on February 08, 2016
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47
Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis (2005) 2.10
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Eur J Clin Microbiol Infect Dis (2006) 1.29
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob (2009) 1.24
Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine (2011) 1.17
Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis (2010) 1.16
In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2012) 1.02
Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol (2010) 1.01
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Clin Microbiol Infect (2011) 0.98
Factors influencing survival in patients with multidrug-resistant Acinetobacter baumannii infection. Braz J Infect Dis (2012) 0.90
[Antibiotic resistance profiles of Acinetobacter species isolated from several clinical samples between 2007-2010]. Mikrobiyol Bul (2011) 0.89
Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2011) 0.89
Epidemiological investigation of nosocomial infection with multidrug-resistant Acinetobacter baumannii. Eur Rev Med Pharmacol Sci (2012) 0.87
First report of New Delhi metallo-β-lactamase-1-producing strains in Slovakia. Microb Drug Resist (2014) 0.86
Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report. Surg Infect (Larchmt) (2011) 0.83
Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific. Scand J Infect Dis (2010) 0.82
Risk factors for mortality in patients with nosocomial Gram-negative rod bacteremia. Eur Rev Med Pharmacol Sci (2013) 0.80
[Analysis of resistance tendency of bloodstream-infecting pathogens in China]. Zhonghua Jie He He Hu Xi Za Zhi (2013) 0.80
Microbiological and molecular detection of VIM-1 metallo beta lactamase-producing Acinetobacter baumannii. Eur Rev Med Pharmacol Sci (2014) 0.80
Fulminating septicemia due to persistent pan-resistant community-acquired metallo-β-lactamase (IMP-1)-positive Acinetobacter baumannii. Indian J Pathol Microbiol (2011) 0.79
[Successful treatment of pan-resistant Acinetobacter baumannii infection of the lung with tigecycline: a report of one case]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue (2013) 0.78
[Clinical characteristics and therapy of pan-drug resistant Acinetobacter baumannii infection]. Nan Fang Yi Ke Da Xue Xue Bao (2010) 0.78
Antibacterial activity of ovary extract from sea urchin Diadema setosum. Eur Rev Med Pharmacol Sci (2015) 0.77
[Intravenous colistin in the treatment of infections due to pan-resistant Gram negative bacilli]. Rev Chilena Infectol (2007) 0.77
Application strategy of PiCCO in septic shock patients. Exp Ther Med (2016) 0.75
Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis. Exp Ther Med (2015) 0.75